213
Views
11
CrossRef citations to date
0
Altmetric
Research Reports

Burden of schizophrenia on selected comorbidity costs

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bruno Emond, Antoine C. El Khoury, Charmi Patel, Dominic Pilon, Laura Morrison, Maryia Zhdanava, Patrick Lefebvre, Neeta Tandon & Kruti Joshi. (2019) Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. Current Medical Research and Opinion 35:3, pages 407-416.
Read now

Articles from other publishers (10)

Luying Wang, Fenghao Shi, Xin Guan, He Xu, Jing Liu & Hongchao Li. (2021) A Systematic Review of Methods and Study Quality of Economic Evaluations for the Treatment of Schizophrenia. Frontiers in Public Health 9.
Crossref
Jose Rodriguez Cruz, Johan Sahlsten Schölin & Stephan Hjorth. (2021) Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction. Frontiers in Psychiatry 12.
Crossref
Thomas E. SmithLeslie A. MarinoMark Olfson. (2021) Unmet Opportunity: Intensive Care Transition Intervention for Individuals With Serious Medical-Psychiatric Illnesses. Psychiatric Services 72:7, pages 856-858.
Crossref
Amy Ronaldson, Lotte Elton, Simone Jayakumar, Anna Jieman, Kristoffer Halvorsrud & Kamaldeep Bhui. (2020) Severe mental illness and health service utilisation for nonpsychiatric medical disorders: A systematic review and meta-analysis. PLOS Medicine 17:9, pages e1003284.
Crossref
Raj DesaiRajesh Nayak. (2019) Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia. Journal of Managed Care & Specialty Pharmacy 25:1, pages 37-46.
Crossref
Charles Laidi, Amélie Prigent, Alice Plas, Marion Leboyer, Guillaume Fond, Karine Chevreul, B. Aouizerate, M. Andre, F. Berna, D. Capdevielle, I. Chereau-Boudet, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Lancon, S. Leigner, P.M. Llorca, J. Mallet, D. Misdrahi, R. Rey, P. Roux, F. Schurhoff, M. Urbach & P. Vidailhet. (2018) Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset. European Neuropsychopharmacology 28:1, pages 24-36.
Crossref
Dominic Pilon, Erik Muser, Patrick Lefebvre, Rhiannon Kamstra, Bruno Emond & Kruti Joshi. (2017) Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia. BMC Psychiatry 17:1.
Crossref
Patrick Lefebvre, Erik Muser, Kruti Joshi, Maral DerSarkissian, Rachel H. Bhak, Mei Sheng Duh, Brian Shiner & Yinong Young-Xu. (2017) Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse. Clinical Therapeutics 39:7, pages 1380-1395.e4.
Crossref
Yajuan Wang, Vijay Iyengar, Jianying Hu, David Kho, Erin Falconer, John P. Docherty & Gigi Y. Yuen. (2017) Predicting Future High-Cost Schizophrenia Patients Using High-Dimensional Administrative Data. Frontiers in Psychiatry 8.
Crossref
Christopher Tsoutsoulas, Benoit H. Mulsant, Sawsan M. Kalache, Sanjeev Kumar, Zaid Ghazala, Aristotle N. Voineskos, Meryl A. Butters, Mahesh Menon & Tarek K. Rajji. (2016) The influence of medical burden severity and cognition on functional competence in older community-dwelling individuals with schizophrenia. Schizophrenia Research 170:2-3, pages 330-335.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.